The future of cardiac output monitoring.

Non-invasive cardiac output measuring.

back to Top

Vital Metrix is a non-invasive, portable technology for hemodynamic monitoring at home, to better manage and potentially reduce the risk of hospital readmission for patients with heart failure.

Vital Metrix is an alternative to currently used invasive procedures that have high risks of complications, and high costs for the patient.

Vital Metrix, with the use of advanced digital signal processing techniques, is capable to extract information contained in the pulse oximeter signal to measure cardiac output, and other hemodynamic parameters of significance.

We help doctors to better treat and manage congestive heart failure.

back to Top

Advantages to patientsNon-invasive measurement with no risk of complications from device implant.

Easy to operate measuring devices, already diffused for in-home use.

Reduced frequency of hospitalization.

Advantages to physiciansEnables periodic monitoring of patient from home.

Continuous monitoring will enable better post-discharge care for cardiac failure patients.

Better information means better care and reduced short-term readmissions.

Vital Metrix development and current status.

back to Top


Algorithm development with $800,000 of SBIR funding from NSF. Preliminary testing and validation at the Heart Center in Huntsville, AL.


One patent issued, one patent allowed, six US and international patents pending. Early discussions with Philips, GE, and Siemens.

Clinical trials.

We are excited to be planning clinical trials at the Centennial Heart here in Nashville(which is part of the HCA system), the Erlanger Hospital in Chattanooga, and Vanderbilt University Medical Center.


back to Top



December 10, 2015 - Vital Metrix is awarded first prize of Alabama Launchpad Competition.

Read more (opens in new window) . . .

October 7, 2015 - Vital Metrix advances to the final round of Alabama Launchpad Competition.

Read more (opens in new window) . . .

August 3, 2015 - Vital Metrix accepted to Jumpstart Foundry’s Health: Further.

Read more (opens in new window) . . .

Contact us

back to Top

For further questions, inquiries and investment opportunities, contact us at: